Hypofractionated Radiosurgery for Localised Prostate Cancer
Condition: Prostate Cancer
Study Type: Interventional
Clinical Trials Identifier NCT 8-digits: NCT03795337
Sponsor: University Hospital Schleswig-Holstein
Eligibility:
- Age: minimum 60 Years maximum N/A
- Gender: Male
Inclusion Criteria:
- non-metastatic, histopathologically confirmed prostate carcinoma cT 1-3 N0 M0
- Gleason-grade ≤7
- Guideline-based staging
- Age ≥ 60 years
- PSA < 15 ng / ml
- Volume of the prostate < 80 cm³
- IPSS-Score ≤ 12
- Written informed consent
Exclusion Criteria:
- Age ≤ 60 years
- History of prior pelvic radiotherapy
- Contraindication to MRI or Fiducial marker implantation (e.g. allergy to gold),
- Immunosuppressive therapy
- Relevant comorbidity thought to adversely affect treatment compliance,
- Legal incapacity or lack of informed consent
View trial on ClinicalTrials.gov